{"product_id":"glow-50-ghk-cu-bpc-157-tb500-peptide-blend","title":"GLOW 50 Research Peptide Blend – 50mg","description":"\u003ch1 data-section-id=\"1jq0vps\" data-start=\"0\" data-end=\"9\"\u003eGLOW 50\u003c\/h1\u003e\n\u003cp data-start=\"11\" data-end=\"63\"\u003e\u003cstrong data-start=\"11\" data-end=\"63\"\u003eGLOW 50 – GHK-Cu + BPC-157 + TB500 Peptide Blend\u003c\/strong\u003e\u003c\/p\u003e\n\u003ch2 data-section-id=\"1qhk4i3\" data-start=\"65\" data-end=\"84\"\u003eSpecifications\u003c\/h2\u003e\n\u003cp data-start=\"85\" data-end=\"277\"\u003e\u003cstrong data-start=\"85\" data-end=\"104\"\u003eGHK-Cu Content:\u003c\/strong\u003e 30mg\u003cbr data-start=\"109\" data-end=\"112\"\u003e\u003cstrong data-start=\"112\" data-end=\"132\"\u003eBPC-157 Content:\u003c\/strong\u003e 10mg\u003cbr data-start=\"137\" data-end=\"140\"\u003e\u003cstrong data-start=\"140\" data-end=\"158\"\u003eTB500 Content:\u003c\/strong\u003e 10mg\u003cbr data-start=\"163\" data-end=\"166\"\u003e\u003cstrong data-start=\"166\" data-end=\"177\"\u003eFormat:\u003c\/strong\u003e Lyophilized Peptide Blend\u003cbr data-start=\"203\" data-end=\"206\"\u003e\u003cstrong data-start=\"206\" data-end=\"216\"\u003eClass:\u003c\/strong\u003e Copper Peptide + Pentadecapeptide + Thymosin Beta-4 Analog\u003c\/p\u003e\n\u003cp data-start=\"279\" data-end=\"368\"\u003e\u003cstrong data-start=\"279\" data-end=\"296\"\u003eIntended Use:\u003c\/strong\u003e For laboratory research purposes only. Not for human or veterinary use.\u003c\/p\u003e\n\u003chr data-start=\"370\" data-end=\"373\"\u003e\n\u003ch2 data-section-id=\"53drpp\" data-start=\"375\" data-end=\"396\"\u003eProduct Overview\u003c\/h2\u003e\n\u003cp data-start=\"398\" data-end=\"696\"\u003eGLOW 50 is a research-grade peptide blend containing GHK-Cu, BPC-157, and TB500. These compounds represent three distinct peptide classes investigated in preclinical models involving extracellular matrix signaling, angiogenesis-related pathways, cytoskeletal regulation, and cellular communication.\u003c\/p\u003e\n\u003cp data-start=\"698\" data-end=\"1079\"\u003eGHK-Cu is an endogenous copper-binding tripeptide studied for gene expression modulation and extracellular matrix-related signaling. BPC-157 is a synthetic gastric pentadecapeptide investigated in vascular signaling and nitric oxide pathway models. TB500 is a synthetic thymosin beta-4 analog studied for actin-binding behavior, cytoskeletal dynamics, and cell migration signaling.\u003c\/p\u003e\n\u003cp data-start=\"1081\" data-end=\"1265\"\u003eBecause direct combined-use data remains limited, GLOW 50 should be understood as a research blend for studying theoretical pathway overlap between these individual peptide mechanisms.\u003c\/p\u003e\n\u003chr data-start=\"1267\" data-end=\"1270\"\u003e\n\u003ch2 data-section-id=\"swov2z\" data-start=\"1272\" data-end=\"1292\"\u003eWhy This Blend?\u003c\/h2\u003e\n\u003cp data-start=\"1294\" data-end=\"1390\"\u003eGLOW 50 combines three peptides commonly studied in overlapping cellular signaling environments:\u003c\/p\u003e\n\u003cul data-start=\"1392\" data-end=\"1641\"\u003e\n\u003cli data-section-id=\"1ryv2t0\" data-start=\"1392\" data-end=\"1475\"\u003e\n\u003cstrong data-start=\"1394\" data-end=\"1405\"\u003eGHK-Cu:\u003c\/strong\u003e Copper binding, gene expression, and extracellular matrix signaling\u003c\/li\u003e\n\u003cli data-section-id=\"1lrmszk\" data-start=\"1476\" data-end=\"1556\"\u003e\n\u003cstrong data-start=\"1478\" data-end=\"1490\"\u003eBPC-157:\u003c\/strong\u003e VEGF-related angiogenesis signaling and nitric oxide modulation\u003c\/li\u003e\n\u003cli data-section-id=\"7m8jdv\" data-start=\"1557\" data-end=\"1641\"\u003e\n\u003cstrong data-start=\"1559\" data-end=\"1569\"\u003eTB500:\u003c\/strong\u003e G-actin binding, cytoskeletal regulation, and cell migration pathways\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"1643\" data-end=\"1846\"\u003eThis blend may be studied in experimental settings where researchers are evaluating interactions between extracellular matrix regulation, vascular signaling markers, and cytoskeletal remodeling pathways.\u003c\/p\u003e\n\u003cp data-start=\"1848\" data-end=\"1939\"\u003eNo synergistic effect should be assumed unless validated through direct experimental study.\u003c\/p\u003e\n\u003chr data-start=\"1941\" data-end=\"1944\"\u003e\n\u003ch2 data-section-id=\"1v7ex7t\" data-start=\"1946\" data-end=\"1970\"\u003eMechanism of Action\u003c\/h2\u003e\n\u003ch3 data-section-id=\"l7ohqe\" data-start=\"1972\" data-end=\"2029\"\u003eGHK-Cu: Copper Binding \u0026amp; Gene Expression Modulation\u003c\/h3\u003e\n\u003cp data-start=\"2031\" data-end=\"2211\"\u003e\u003cstrong data-start=\"2031\" data-end=\"2058\"\u003eCopper Ion Coordination\u003c\/strong\u003e\u003cbr data-start=\"2058\" data-end=\"2061\"\u003eGHK-Cu is investigated for its ability to bind copper(II), forming a biologically relevant peptide-metal complex studied in cellular signaling models.\u003c\/p\u003e\n\u003cp data-start=\"2213\" data-end=\"2429\"\u003e\u003cstrong data-start=\"2213\" data-end=\"2242\"\u003eGene Expression Signaling\u003c\/strong\u003e\u003cbr data-start=\"2242\" data-end=\"2245\"\u003eGHK-Cu has been evaluated in research involving transcriptional regulation and gene expression patterns associated with extracellular matrix maintenance and cellular response pathways.\u003c\/p\u003e\n\u003cp data-start=\"2431\" data-end=\"2628\"\u003e\u003cstrong data-start=\"2431\" data-end=\"2463\"\u003eExtracellular Matrix Context\u003c\/strong\u003e\u003cbr data-start=\"2463\" data-end=\"2466\"\u003eResearch involving GHK-Cu often focuses on matrix-associated signaling, including collagen-related pathways, protease regulation, and fibroblast signaling models.\u003c\/p\u003e\n\u003chr data-start=\"2630\" data-end=\"2633\"\u003e\n\u003ch3 data-section-id=\"1e3vy7k\" data-start=\"2635\" data-end=\"2691\"\u003eBPC-157: Vascular \u0026amp; Nitric Oxide Pathway Signaling\u003c\/h3\u003e\n\u003cp data-start=\"2693\" data-end=\"2842\"\u003e\u003cstrong data-start=\"2693\" data-end=\"2719\"\u003eVEGF-Related Signaling\u003c\/strong\u003e\u003cbr data-start=\"2719\" data-end=\"2722\"\u003eBPC-157 has been studied in models examining VEGF\/VEGFR2-associated pathways and angiogenesis-related signaling markers.\u003c\/p\u003e\n\u003cp data-start=\"2844\" data-end=\"3003\"\u003e\u003cstrong data-start=\"2844\" data-end=\"2871\"\u003eNitric Oxide Modulation\u003c\/strong\u003e\u003cbr data-start=\"2871\" data-end=\"2874\"\u003eBPC-157 is investigated in relation to nitric oxide-dependent vascular signaling and experimental models of vasomotor regulation.\u003c\/p\u003e\n\u003cp data-start=\"3005\" data-end=\"3217\"\u003e\u003cstrong data-start=\"3005\" data-end=\"3041\"\u003eCellular Stress Response Context\u003c\/strong\u003e\u003cbr data-start=\"3041\" data-end=\"3044\"\u003ePreclinical studies also examine BPC-157 in models involving cellular signaling under stress conditions, with focus on pathway-level responses rather than clinical outcomes.\u003c\/p\u003e\n\u003chr data-start=\"3219\" data-end=\"3222\"\u003e\n\u003ch3 data-section-id=\"1je4k0z\" data-start=\"3224\" data-end=\"3274\"\u003eTB500: Actin Binding \u0026amp; Cytoskeletal Dynamics\u003c\/h3\u003e\n\u003cp data-start=\"3276\" data-end=\"3411\"\u003e\u003cstrong data-start=\"3276\" data-end=\"3301\"\u003eG-Actin Sequestration\u003c\/strong\u003e\u003cbr data-start=\"3301\" data-end=\"3304\"\u003eTB500 is associated with thymosin beta-4 biology, particularly G-actin binding and cytoskeletal regulation.\u003c\/p\u003e\n\u003cp data-start=\"3413\" data-end=\"3586\"\u003e\u003cstrong data-start=\"3413\" data-end=\"3441\"\u003eCell Migration Signaling\u003c\/strong\u003e\u003cbr data-start=\"3441\" data-end=\"3444\"\u003eThymosin beta-4 analogs are studied in models examining cell movement, cytoskeletal organization, and migration-associated signaling pathways.\u003c\/p\u003e\n\u003cp data-start=\"3588\" data-end=\"3754\"\u003e\u003cstrong data-start=\"3588\" data-end=\"3616\"\u003eTissue Signaling Context\u003c\/strong\u003e\u003cbr data-start=\"3616\" data-end=\"3619\"\u003eTB500 is evaluated in preclinical models involving structural signaling, cellular organization, and actin-dependent pathway regulation.\u003c\/p\u003e\n\u003chr data-start=\"3756\" data-end=\"3759\"\u003e\n\u003ch2 data-section-id=\"1k1p0ls\" data-start=\"3761\" data-end=\"3792\"\u003ePreclinical Research Areas\u003c\/h2\u003e\n\u003cp data-start=\"3794\" data-end=\"4007\"\u003e\u003cstrong data-start=\"3794\" data-end=\"3844\"\u003e1. Extracellular Matrix \u0026amp; Fibroblast Signaling\u003c\/strong\u003e\u003cbr data-start=\"3844\" data-end=\"3847\"\u003eGHK-Cu is studied in models involving extracellular matrix regulation, fibroblast signaling, and gene expression patterns related to matrix-associated pathways.\u003c\/p\u003e\n\u003cp data-start=\"4009\" data-end=\"4192\"\u003e\u003cstrong data-start=\"4009\" data-end=\"4056\"\u003e2. Angiogenesis \u0026amp; Vascular Signaling Models\u003c\/strong\u003e\u003cbr data-start=\"4056\" data-end=\"4059\"\u003eBPC-157 is investigated in preclinical models examining VEGF-related signaling, VEGFR2 activity, and nitric oxide pathway modulation.\u003c\/p\u003e\n\u003cp data-start=\"4194\" data-end=\"4349\"\u003e\u003cstrong data-start=\"4194\" data-end=\"4248\"\u003e3. Cytoskeletal Dynamics \u0026amp; Cell Migration Research\u003c\/strong\u003e\u003cbr data-start=\"4248\" data-end=\"4251\"\u003eTB500\/thymosin beta-4 analogs are studied for actin-binding behavior and cell migration signaling.\u003c\/p\u003e\n\u003cp data-start=\"4351\" data-end=\"4557\"\u003e\u003cstrong data-start=\"4351\" data-end=\"4405\"\u003e4. Cellular Communication \u0026amp; Pathway Overlap Models\u003c\/strong\u003e\u003cbr data-start=\"4405\" data-end=\"4408\"\u003eThe combination may be studied in experimental models evaluating overlap between matrix signaling, vascular signaling, and cytoskeletal organization.\u003c\/p\u003e\n\u003cp data-start=\"4559\" data-end=\"4788\"\u003e\u003cstrong data-start=\"4559\" data-end=\"4612\"\u003e5. Peptide Blend Stability \u0026amp; Formulation Research\u003c\/strong\u003e\u003cbr data-start=\"4612\" data-end=\"4615\"\u003eAs a multi-peptide lyophilized blend, GLOW 50 may be evaluated in research workflows involving peptide stability, reconstitution behavior, and combined-formulation handling.\u003c\/p\u003e\n\u003chr data-start=\"4790\" data-end=\"4793\"\u003e\n\u003ch2 data-section-id=\"ce0tqk\" data-start=\"4795\" data-end=\"4812\"\u003eApplications\u003c\/h2\u003e\n\u003cul data-start=\"4814\" data-end=\"5081\"\u003e\n\u003cli data-section-id=\"4yo3hu\" data-start=\"4814\" data-end=\"4856\"\u003eExtracellular matrix signaling studies\u003c\/li\u003e\n\u003cli data-section-id=\"upr33h\" data-start=\"4857\" data-end=\"4895\"\u003eFibroblast and cell culture models\u003c\/li\u003e\n\u003cli data-section-id=\"1qa0lmf\" data-start=\"4896\" data-end=\"4928\"\u003eVEGF\/VEGFR2 pathway analysis\u003c\/li\u003e\n\u003cli data-section-id=\"1j8ww9n\" data-start=\"4929\" data-end=\"4964\"\u003eNitric oxide signaling research\u003c\/li\u003e\n\u003cli data-section-id=\"fnv9jv\" data-start=\"4965\" data-end=\"5007\"\u003eCytoskeletal and actin-binding studies\u003c\/li\u003e\n\u003cli data-section-id=\"quyk8p\" data-start=\"5008\" data-end=\"5043\"\u003eCell migration pathway research\u003c\/li\u003e\n\u003cli data-section-id=\"vzb3pq\" data-start=\"5044\" data-end=\"5081\"\u003eMulti-peptide formulation studies\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-start=\"5083\" data-end=\"5086\"\u003e\n\u003ch2 data-section-id=\"1jtb6ys\" data-start=\"5088\" data-end=\"5112\"\u003eResearch Advantages\u003c\/h2\u003e\n\u003cul data-start=\"5114\" data-end=\"5483\"\u003e\n\u003cli data-section-id=\"d9i1pw\" data-start=\"5114\" data-end=\"5179\"\u003eCombines three distinct peptide classes in one research blend\u003c\/li\u003e\n\u003cli data-section-id=\"68tq68\" data-start=\"5180\" data-end=\"5264\"\u003eIncludes copper peptide, pentadecapeptide, and thymosin beta-4 analog mechanisms\u003c\/li\u003e\n\u003cli data-section-id=\"fasst8\" data-start=\"5265\" data-end=\"5346\"\u003eRelevant to extracellular matrix, vascular, and cytoskeletal pathway research\u003c\/li\u003e\n\u003cli data-section-id=\"xodn8k\" data-start=\"5347\" data-end=\"5409\"\u003eLyophilized format supports controlled laboratory handling\u003c\/li\u003e\n\u003cli data-section-id=\"15vska8\" data-start=\"5410\" data-end=\"5483\"\u003eUseful for studying theoretical pathway overlap in preclinical models\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-start=\"5485\" data-end=\"5488\"\u003e\n\u003ch2 data-section-id=\"1qk69px\" data-start=\"5490\" data-end=\"5513\"\u003eStorage \u0026amp; Handling\u003c\/h2\u003e\n\u003cp data-start=\"5515\" data-end=\"5562\"\u003e\u003cstrong data-start=\"5515\" data-end=\"5534\"\u003ePhysical State:\u003c\/strong\u003e Lyophilized peptide blend\u003c\/p\u003e\n\u003cp data-start=\"5564\" data-end=\"5625\"\u003e\u003cstrong data-start=\"5564\" data-end=\"5576\"\u003eStorage:\u003c\/strong\u003e Store at -20°C in a dry, protected environment\u003c\/p\u003e\n\u003cp data-start=\"5627\" data-end=\"5719\"\u003e\u003cstrong data-start=\"5627\" data-end=\"5646\"\u003eReconstitution:\u003c\/strong\u003e Use appropriate sterile laboratory solvent under controlled conditions\u003c\/p\u003e\n\u003cp data-start=\"5721\" data-end=\"5820\"\u003e\u003cstrong data-start=\"5721\" data-end=\"5734\"\u003eHandling:\u003c\/strong\u003e Avoid repeated freeze-thaw cycles. Use aliquots where possible after reconstitution\u003c\/p\u003e\n\u003cp data-start=\"5822\" data-end=\"5927\"\u003e\u003cstrong data-start=\"5822\" data-end=\"5855\"\u003eLight \u0026amp; Moisture Sensitivity:\u003c\/strong\u003e Protect from light, moisture, and prolonged room-temperature exposure\u003c\/p\u003e\n\u003chr data-start=\"5929\" data-end=\"5932\"\u003e\n\u003ch2 data-section-id=\"9rcx7q\" data-start=\"5934\" data-end=\"5949\"\u003eDisclaimer\u003c\/h2\u003e\n\u003cp data-start=\"5951\" data-end=\"6275\"\u003eFOR RESEARCH USE ONLY. This product is a chemical compound intended strictly for laboratory research and development. It is not approved by the FDA for clinical use, diagnostics, or therapeutic procedures in humans or animals. The physiological and toxicological properties of this chemical have not been fully investigated.\u003c\/p\u003e","brand":"Peptagon","offers":[{"title":"Default Title","offer_id":48170514153686,"sku":"GLOW-50","price":47.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0783\/3085\/5638\/files\/GLOW-50-GHK-CU-30mg-BPC-157-10mg-TB500-10mg.png?v=1777487064","url":"https:\/\/peptagon.com\/products\/glow-50-ghk-cu-bpc-157-tb500-peptide-blend","provider":"Peptagon","version":"1.0","type":"link"}